» Articles » PMID: 9223312

Fusion Genes Resulting from Alternative Chromosomal Translocations Are Overexpressed by Gene-specific Mechanisms in Alveolar Rhabdomyosarcoma

Overview
Specialty Science
Date 1997 Jul 22
PMID 9223312
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Chromosomal translocations identified in hematopoietic and solid tumors result in deregulated expression of protooncogenes or creation of chimeric proteins with tumorigenic potential. In the pediatric solid tumor alveolar rhabdomyosarcoma, a consistent t(2;13)(q35;q14) or variant t(1;13)(p36;q14) translocation generates PAX3-FKHR or PAX7-FKHR fusion proteins, respectively. In this report, we demonstrate that in addition to functional alterations these translocations are associated with fusion product overexpression. Furthermore, PAX3-FKHR and PAX7-FKHR overexpression occurs by distinct mechanisms. Transcription of PAX3-FKHR is increased relative to wild-type PAX3 by a copy number-independent process. In contrast, PAX7-FKHR overexpression results from fusion gene amplification. Thus, gene-specific mechanisms were selected to overexpress PAX3-FKHR and PAX7-FKHR in alveolar rhabdomyosarcoma, presumably due to differences in regulation between the wild-type loci. We postulate that these overexpression mechanisms ensure a critical level of gene product for the oncogenic effects of these fusions.

Citing Articles

We need to talk-how muscle stem cells communicate.

Majchrzak K, Hentschel E, Honzke K, Geithe C, von Maltzahn J Front Cell Dev Biol. 2024; 12:1378548.

PMID: 39050890 PMC: 11266305. DOI: 10.3389/fcell.2024.1378548.


The PAX Genes: Roles in Development, Cancer, and Other Diseases.

Shaw T, Barr F, Uren A Cancers (Basel). 2024; 16(5).

PMID: 38473380 PMC: 10931086. DOI: 10.3390/cancers16051022.


Myo-differentiation reporter screen reveals NF-Y as an activator of PAX3-FOXO1 in rhabdomyosarcoma.

Sroka M, Skopelitis D, Vermunt M, Preall J, El Demerdash O, de Almeida L Proc Natl Acad Sci U S A. 2023; 120(36):e2303859120.

PMID: 37639593 PMC: 10483665. DOI: 10.1073/pnas.2303859120.


The 3D chromatin landscape of rhabdomyosarcoma.

Wang M, Sreenivas P, Sunkel B, Wang L, Ignatius M, Stanton B NAR Cancer. 2023; 5(3):zcad028.

PMID: 37325549 PMC: 10261698. DOI: 10.1093/narcan/zcad028.


The Cytotoxic Effect of Curcumin in Rhabdomyosarcoma Is Associated with the Modulation of AMPK, AKT/mTOR, STAT, and p53 Signaling.

Salucci S, Bavelloni A, Stella A, Fabbri F, Vannini I, Piazzi M Nutrients. 2023; 15(3).

PMID: 36771452 PMC: 9920154. DOI: 10.3390/nu15030740.


References
1.
Dani C, Piechaczyk M, Audigier Y, El Sabouty S, Cathala G, Marty L . Characterization of the transcription products of glyceraldehyde 3-phosphate-dehydrogenase gene in HeLa cells. Eur J Biochem. 1984; 145(2):299-304. DOI: 10.1111/j.1432-1033.1984.tb08552.x. View

2.
Bernasconi M, Remppis A, Fredericks W, Rauscher 3rd F, Schafer B . Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins. Proc Natl Acad Sci U S A. 1996; 93(23):13164-9. PMC: 24064. DOI: 10.1073/pnas.93.23.13164. View

3.
Goulding M, Chalepakis G, Deutsch U, Erselius J, Gruss P . Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J. 1991; 10(5):1135-47. PMC: 452767. DOI: 10.1002/j.1460-2075.1991.tb08054.x. View

4.
Jostes B, Walther C, Gruss P . The murine paired box gene, Pax7, is expressed specifically during the development of the nervous and muscular system. Mech Dev. 1990; 33(1):27-37. DOI: 10.1016/0925-4773(90)90132-6. View

5.
Biegel J, Meek R, Parmiter A, Conard K, Emanuel B . Chromosomal translocation t(1;13)(p36;q14) in a case of rhabdomyosarcoma. Genes Chromosomes Cancer. 1991; 3(6):483-4. DOI: 10.1002/gcc.2870030612. View